Literature DB >> 9375252

Site-specific incorporation of biotinylated amino acids to identify surface-exposed residues in integral membrane proteins.

J P Gallivan1, H A Lester, D A Dougherty.   

Abstract

BACKGROUND: A key structural issue for all integral membrane proteins is the exposure of individual residues to the intracellular or extracellular media. This issue involves the basic transmembrane topology as well as more subtle variations in surface accessibility. Direct methods to evaluate the degree of exposure for residues in functional proteins expressed in living cells would be highly valuable. We sought to develop a new experimental method to determine highly surface-exposed residues, and thus transmembrane topology of membrane proteins expressed in Xenopus oocytes.
RESULTS: We have used the in vivo nonsense suppression technique to incorporate biotinylated unnatural amino acids into functional ion channels expressed in Xenopus oocytes. Binding of 125I-streptavidin to biotinylated receptors was used to determine the surface exposure of individual amino acids. In particular, we studied the main immunogenic region of the nicotinic acetylcholine receptor. The biotin-containing amino acid biocytin was efficiently incorporated into five sites in the main immunogenic region and extracellular streptavidin bound to one residue in particular, alpha 70. The position of alpha 70 as highly exposed on the receptor surface was thus established.
CONCLUSIONS: The in vivo nonsense suppression technique has been extended to provide the first in a potential series of methods to identify exposed residues and to assess their relative exposure in functional proteins expressed in Xenopus oocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375252     DOI: 10.1016/s1074-5521(97)90312-4

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  9 in total

1.  Monitoring mis-acylated tRNA suppression efficiency in mammalian cells via EGFP fluorescence recovery.

Authors:  Erwin Ilegems; Horst M Pick; Horst Vogel
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Programming peptidomimetic syntheses by translating genetic codes designed de novo.

Authors:  Anthony C Forster; Zhongping Tan; Madhavi N L Nalam; Hening Lin; Hui Qu; Virginia W Cornish; Stephen C Blacklow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

3.  Identification of interface residues in protease-inhibitor and antigen-antibody complexes: a support vector machine approach.

Authors:  Changhui Yan; Vasant Honavar; Drena Dobbs
Journal:  Neural Comput Appl       Date:  2004-06-01       Impact factor: 5.606

4.  Synthesis of a biotin-derived alkyne for pd-catalyzed coupling reactions.

Authors:  Cesear Corona; Bj K Bryant; Jeffrey B Arterburn
Journal:  Org Lett       Date:  2006-04-27       Impact factor: 6.005

Review 5.  In vivo incorporation of non-canonical amino acids by using the chemical aminoacylation strategy: a broadly applicable mechanistic tool.

Authors:  Dennis A Dougherty; Ethan B Van Arnam
Journal:  Chembiochem       Date:  2014-07-02       Impact factor: 3.164

6.  Single-molecule imaging of a fluorescent unnatural amino acid incorporated into nicotinic receptors.

Authors:  Rigo Pantoja; Erik A Rodriguez; Mohammed I Dibas; Dennis A Dougherty; Henry A Lester
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 7.  Recent progress in enzymatic protein labelling techniques and their applications.

Authors:  Yi Zhang; Keun-Young Park; Kiall F Suazo; Mark D Distefano
Journal:  Chem Soc Rev       Date:  2018-09-27       Impact factor: 54.564

8.  Improved amber and opal suppressor tRNAs for incorporation of unnatural amino acids in vivo. Part 1: minimizing misacylation.

Authors:  Erik A Rodriguez; Henry A Lester; Dennis A Dougherty
Journal:  RNA       Date:  2007-08-13       Impact factor: 4.942

9.  Site-specific biotinylation of purified proteins using BirA.

Authors:  Michael Fairhead; Mark Howarth
Journal:  Methods Mol Biol       Date:  2015
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.